BENZINGA Chicago Interviews: Dr. David Cunic: UCS Advisors

About the Author: HCN News Team

The News Team at Highly Capitalized are some of the most experienced writers in cannabis and psychedelics business & finance. We cover capital markets, finance, branding, marketing and everything important in between. Most of all, we follow the money.

Share This Story, Choose Your Platform!

Related Posts

HCN Interviews: Dan Herer: Founder: Herer Brands
The Ohio Classic Interviews: Juliana Whitney: Founder & CEO of Cann Strategy
Emerald Cup Interviews: Mara Gordon: Founder of Aunt Zelda’s
Emerald Cup Interviews: Derek Dauchan: Ambassador: Urbana
Emerald Cup Interviews: Trip Mekki: Retail Manager, Urbana

Latest News

Compass Pathways Advances Psilocybin Research in the UK

January 13th, 2025|

LOS ANGELES- Compass Pathways, a biotechnology company specializing in mental health innovations, has commenced the UK segment of its global Phase 3 clinical trial evaluating COMP360 psilocybin therapy for treatment-resistant depression (TRD). This initiative follows ...